A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2001
12/05/2001	EP1159299A1 Mammalian cytokines; related reagents and methods
12/05/2001	EP1159291A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
12/05/2001	EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta
12/05/2001	EP1159284A1 33 human secreted proteins
12/05/2001	EP1159275A2 Imidazole compounds as histamine h3 ligands
12/05/2001	EP1159273A1 Compounds useful as reversible inhibitors of cathepsin s
12/05/2001	EP1159002A2 Emulsan and emulsan analogs immunization formulations and use
12/05/2001	EP1158999A2 Methods for improving graft acceptance in a recipient by administration of a cytokine profile altering agent
12/05/2001	EP1158996A1 Novel amide derivatives as growth hormone secretagogues
12/05/2001	EP1158993A1 Bacterial membrane fractions with adjuvant effect
12/05/2001	EP1158990A1 Administration of an anti-endotoxin drug by intravenous infusion
12/05/2001	EP1158958A1 Improved powdery pharmaceutical compositions for inhalation
12/05/2001	EP1142903A9 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb 1?
12/05/2001	EP1067904B1 Solid, quick dissolving cetirizine formulations
12/05/2001	EP0835263B1 Somatostatin peptides
12/05/2001	EP0783522B1 PEPTIDES FROM THE hPTH SEQUENCE (1-37)
12/05/2001	EP0745075B1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/05/2001	EP0745071B1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
12/05/2001	EP0720484B1 Plant material for controlling immune responses in mammals and method for producing the material
12/05/2001	EP0643701B1 Benzimidazole-derived compounds, method for preparing same, and therapeutical and cosmetic uses thereof
12/05/2001	EP0636026B1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
12/05/2001	EP0605493B1 THIADIAZOLO (4,3-a)PYRIDINE DERIVATIVES, METHODS OF PREPARING THEM AND DRUGS CONTAINING THEM
12/05/2001	EP0445255B2 USE OF HYALURONIC ACID IN COMBINATION WITH ASCORBIC ACID, ANTITUMOUR AGENTS AND/OR NSAIDs FOR TREATING CANCER
12/05/2001	CN1325441A Modified exosomes and uses
12/05/2001	CN1325408A Compounds with growth hormone releasing propenties
12/05/2001	CN1325390A 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/05/2001	CN1325389A 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/05/2001	CN1325376A Novel compounds and medicinal use thereof
12/05/2001	CN1325303A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses
12/05/2001	CN1325302A Use of dialkylfumarates
12/05/2001	CN1325299A Orally administered controlled drug delivery system providing temporal and spatial control
12/05/2001	CN1325271A Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
12/05/2001	CN1324946A New polypeptide human ATP dependent RNA unwinding enzyme 11 and polynucleotides for encoding same
12/05/2001	CN1324656A Chinese medicine prepn. with immunity strengthening effect
12/05/2001	CN1324615A Medicine for treating lupus erythematosus
12/05/2001	CN1075816C Methods for in vivo reduction of nitric oxide levels and compositions sueful therefor
12/05/2001	CN1075809C Novel vitamin D analogues
12/04/2001	US6326510 Skin disorders; anticancer agents
12/04/2001	US6326500 Imidazole derivatives for blocking the release of arachidonic acid from phospholipids
12/04/2001	US6326388 Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
12/04/2001	US6326385 Administering poltassium channel modulator
12/04/2001	US6326355 Method for the prevention and treatment of cachexia and anorexia
12/04/2001	US6326353 123therapy for septic shock; administering polymyxin by injection
12/04/2001	US6326352 Compounds and methods for modulating cell adhesion
12/04/2001	US6326179 Enzymatic immunoglobulin; for use as therapeutic and diagnostic tools in treatment of arthritis, viral disease and alzheimer's disease
12/04/2001	US6326010 Comprising main body and head portion formed by hermetic sealing; restrains formation of thermally denatured albumin by filling in sterilized state without atmosphere exposure
12/04/2001	US6326001 Recombinant vaccine for diseases caused by encapsulated organisms
12/04/2001	US6325999 Use of Fas ligand to suppress T-lymphocyte-mediated immune responses
12/04/2001	US6325989 Glycoprotein having no adenosine deaminase type-1 activity
12/04/2001	CA2208836C Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
12/01/2001	CA2347276A1 I g e-dependent histamine-releasing factor (hrf) receptor, hrf-binding peptides and nucleic acids encoding the same, and uses thereof
11/2001
11/30/2001	CA2348847A1 New isoxazole-sulfonamide endothelin antagonists
11/29/2001	WO2001090747A2 Modulation of t-cell receptor interactions
11/29/2001	WO2001090404A1 Drug screening systems and assays
11/29/2001	WO2001090361A2 Modulation of inflammation by protease-treated mcp-3 chemokine
11/29/2001	WO2001090359A2 G-protein coupled receptors
11/29/2001	WO2001090358A2 Mammalian receptor proteins; related reagents and methods
11/29/2001	WO2001090342A2 Genetic engineering of vascular grafts to resist disease
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090332A2 Dna repair polypeptides and methods of use
11/29/2001	WO2001090330A2 AMINOACYL tRNA SYNTHETASES
11/29/2001	WO2001090316A2 Human circulating dendritic cell compositions and methods
11/29/2001	WO2001090311A1 Novel probiotics for pet food applications
11/29/2001	WO2001090197A1 Synthetic peptides and uses therefore
11/29/2001	WO2001090186A1 Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof
11/29/2001	WO2001090182A2 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/29/2001	WO2001090153A2 Reagents for cell selection and methods of use
11/29/2001	WO2001090151A2 Human receptor proteins; related reagents and methods
11/29/2001	WO2001090129A2 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds
11/29/2001	WO2001090110A1 Macrolides
11/29/2001	WO2001090106A2 Tryasolyl tropane derivatives as ccr5 modulators
11/29/2001	WO2001090104A2 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
11/29/2001	WO2001090103A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001	WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001	WO2001090083A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
11/29/2001	WO2001090076A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001090068A2 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001090060A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001	WO2001090059A1 Aniline disulfide derivatives for treating allergic diseases
11/29/2001	WO2001089574A1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
11/29/2001	WO2001089569A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
11/29/2001	WO2001089563A1 Recombinant or purified polyclonal antibodies for treating allergy
11/29/2001	WO2001089557A2 Methods for preventing strokes by inducing tolerance to e-selectin
11/29/2001	WO2001089549A2 Therapeutic uses of il-1 receptor antagonist
11/29/2001	WO2001089539A2 Methods for restoring or enhancing t-cell immune surveillance following naturally or artifically induced immunosuppression
11/29/2001	WO2001089538A2 Apoptotic entities for use in treatment of endothelium dysfunction disorders
11/29/2001	WO2001089537A2 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
11/29/2001	WO2001089536A2 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/29/2001	WO2001089504A1 Tropolone derivatives and pharmaceutical compositions
11/29/2001	WO2001089493A2 Compositions containing a benzamide disulfide derivative for treating allergic diseases
11/29/2001	WO2001089457A2 Thrombopoietin mimetics
11/29/2001	WO2001089451A2 Protease inhibitors
11/29/2001	WO2001089286A2 T cell binding ligand peptides, peptide constructs containing same and use thereof for treatment of immunological disorders

1 ... 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 ... 1172